‘Viread’ will be recommended for most hepatitis B MDR patients

Published: 2014-10-28 15:01:10

Updated: 2014-10-28 15:01:10

A domestic guideline that recommends exclusive prescription of ‘Viread’ to hepatitis B MDR (multiple drug resistance) patients will be introduced.

The Korean Association for the Study of the Liver (KASL) announced to introduce the guideline at ‘the 20^th KASL Autumn Academic Conference and General Meeting’ in Seoul COEX on the 27^th.

The guideline update of the academic conference is directly c...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.